Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 2.59% | 60.68 | 0.0% | $930.66m | |
| NVAX | Novavax, Inc. | 36.12% | 108.13 | 102.0% | $754.24m | |
| AMGN | Amgen, Inc. | -0.49% | 255.00 | 1.3% | $745.88m | |
| GILD | Gilead Sciences, Inc. | -0.19% | 76.62 | 1.0% | $693.12m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 3.46% | 648.97 | 2.5% | $685.20m | |
| BIIB | Biogen, Inc. | 0.59% | 271.40 | 1.6% | $581.49m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 3.97% | 302.87 | 1.9% | $531.71m | |
| ILMN | Illumina, Inc. | -0.76% | 376.52 | 3.5% | $302.41m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.50% | 113.00 | 2.0% | $234.30m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.96% | 128.94 | 4.3% | $219.55m | |
| SGEN | Seattle Genetics, Inc. | 4.61% | 178.30 | 6.1% | $207.89m | |
| SRNE | Sorrento Therapeutics, Inc. | 2.99% | 7.38 | 1.8% | $197.64m | |
| IMMU | Immunomedics, Inc. | 1.30% | 41.16 | 11.0% | $181.04m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.73% | 166.32 | 13.9% | $174.11m | |
| INCY | Incyte Corp. | 0.95% | 108.81 | 2.5% | $165.88m |
Company Profile
Actinium Pharmaceuticals, Inc. is a biopharmaceutical company. It is focused on developing Antibody Radiation-Conjugates, which combine the targeting ability of antibodies with the cell killing ability of radiation. Its product pipeline includes Iomab-B, Actimab-A, and Actimab-M. The company was founded in 1993 and is headquartered in New York, NY.